Digestive Diseases and Sciences

, Volume 53, Issue 12, pp 3250–3258 | Cite as

Whipple’s Disease—Generalized Stage

  • Peter JackuliakEmail author
  • Tomas Koller
  • Lahim Baqi
  • Lukas Plank
  • Zora Lasabova
  • Gabriel Minarik
  • Juraj Payer


Whipple’s disease is a chronic inflammatory systemic disorder in which all organs can be invaded by the rod-shaped bacterium Tropheryma whipplei. It is a rare disease and frequently misdiagnosed, though there is no valid estimate of its actual incidence and prevalence. Only about 1,000–1,500 cases have been reported. The clinical course of untreated Whipple’s disease can include three stages: (1) a non-specific prodromal stage which includes migratory polyarthralgias; (2) a classic abdominal manifestation which involves weight loss, weakness, chronic diarrhea, and abdominal pain; and (3) a generalized stage characterized by steatorhea, cachexia, lymphadenopathy, hyper-pigmentation, and cardiovascular, pulmonary, and neurological dysfunction. The authors describe a case of a 39-year-old male patient with about a year’s history of generalized adenopathy, inappetence, weight loss, progressive weakness, subfebrilities, and convulsive abdominal pain. Following primary exclusion of a tumor disease, a lymph node biopsy demonstrated a typical picture of a granulomatous inflammation—Whipple’s lymphadenitis with partial exemption of the Gram reaction, and stain features corresponding to T. whipplei, which is regarded as the etiological agent causing this disorder. Further tests confirmed the generalized form of the disorder, affecting the lymphatic tissues, gastrointestinal system, respiratory system, and nervous system, with sensory and motor polyneuropathy. HLA-B27 antigen, which is frequent among those with Whipple’s disease, was also present. Following treatment for three months with antibiotics a significant reduction of the changes typical of Whipple’s disease was found upon follow-up biopsy, hence we assume the applied therapy was successful. In our case study we emphasize the atypical course of the disease with dominant generalized lymphadenopathy and only mild gastrointestinal symptoms.


Morbus Whipplei Tropheryma whipplei Gastrointestinal symptoms Lymphadenopathia 


  1. 1.
    Whipple GH (1907) A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 18:382–391Google Scholar
  2. 2.
    Cooper GS, Blades EW, Remler BF, Salata RA, Bennert KW, Jacobs GH (1994) Central nervous system Whipple’s disease: relapse during therapy with trimethoprim-sulfamethoxazole and remission with cefixime. Gastroenterology 106:782–786PubMedGoogle Scholar
  3. 3.
    Black-Schaffer B (1949) The tinctorial demonstration of a glycoprotein in Whipple’s disease. Proc Soc Exp Biol Med 72:225–227PubMedGoogle Scholar
  4. 4.
    Paulley JW (1952) A case report of Whipple’s disease (intestinal lipodystrophy). Gastroenterology 22:128–32PubMedGoogle Scholar
  5. 5.
    Ehrbar HU, Bauerfeind P, Dutly F, Koelz HR, Altwegg M (1999) PCR-positive tests for Tropheryma whippeli in patients without Whipple’s disease. Lancet 353:2214. doi: 10.1016/S0140-6736(99)01776-6 PubMedCrossRefGoogle Scholar
  6. 6.
    Wilson KH, Blitchington R, Frothingham R, Wilson JAP (1991) Phylogeny of the Whipple’s disease-associated bacterium. Lancet 338:474–475. doi: 10.1016/0140-6736(91)90545-Z PubMedCrossRefGoogle Scholar
  7. 7.
    Relman DA, Schmidt TM, MacDermott RP, Falkow S (1992) Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 327:293–301PubMedGoogle Scholar
  8. 8.
    Raoult D, Birg ML, La Scola B et al (2000) Cultivation of the bacillus of Whipple’s disease. N Engl J Med 342:620–625. doi: 10.1056/NEJM200003023420903 PubMedCrossRefGoogle Scholar
  9. 9.
    Raoult D, Lepidi H (2001) Tropheryma whippeli circulating in blood monocytes. N Engl J Med 345:548. doi: 10.1056/NEJM200108163450716 PubMedCrossRefGoogle Scholar
  10. 10.
    La Scola B, Fenollar F, Fournier PE, Altwegg M, Mallet MM, Raoult D (2001) Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple’s disease bacillus. Int J Syst Evol Microbiol 51:1471–1479PubMedGoogle Scholar
  11. 11.
    Vital-Durand D, Lecomte C, Cathebras P, Rousset H, Godeau P (1997) Whipple disease clinical review of 52 cases. The SNFMI research group on Whipple’s disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore) 76:170–184. doi: 10.1097/00005792-199705000-00003 CrossRefGoogle Scholar
  12. 12.
    Dobbins WO. Whipple’s disease. Charles C Thomas, Springfield 1987, IIIGoogle Scholar
  13. 13.
    Gunia S, Behrens MH, Stosiek P (2004) A rare course of Whipple’s disease with atypical cardiac manifestation. AMPIS 112:222–224Google Scholar
  14. 14.
    Fenollar F, Raoult D (2001) Whipple’s disease. Clin Diag Lab Immunol 8:1–8. doi: 10.1128/CDLI.8.1.1-8.2001 CrossRefGoogle Scholar
  15. 15.
    Rickman LS, Freeman WR, Green WR et al (1995) Brief report: uveitis caused by Tropheryma whippeli (Whipple’s bacillus). N Engl J Med 332:363–366. doi: 10.1056/NEJM199502093320604 PubMedCrossRefGoogle Scholar
  16. 16.
    Maiwald M, Ditton HJ, von Herbay A et al (1996) Reassessment of the phylogenetic position of the bacterium associated with Whipple’s disease and determination of the 16S-23S ribosomal intergenic spacer sequence. Int J Syst Bacteriol 46:3292–3297CrossRefGoogle Scholar
  17. 17.
    Puécha X (2001) Whipple disease and arthritis. Curr Opin Rheumatol 13:74–79. doi: 10.1097/00002281-200101000-00012 CrossRefGoogle Scholar
  18. 18.
    Fleming JL, Weisner RH, Shorter RG (1988) Whipple’s disease: clinical, biochemical, and histopathological features, and assessment of treatment in 29 patients. Mayo Clin Proc 63:539–551PubMedGoogle Scholar
  19. 19.
    James TN, Bulkley BH (1983) Abnormalities of the coronary arteries in Whipple’s disease. Am Heart J 105:481–491. doi: 10.1016/0002-8703(83)90367-8 PubMedCrossRefGoogle Scholar
  20. 20.
    McAllister Jr HA, Fenoglio JJ (1975) Cardiac involvement in Whipple’s disease. Circulation 52:152–156PubMedGoogle Scholar
  21. 21.
    Schwarzt MN (2000) Whipple’s disease-past, present, and future. N Engl J Med 342:648–650. doi: 10.1056/NEJM200003023420908 CrossRefGoogle Scholar
  22. 22.
    Dutly F, Altwegg M (2001) Whipple’s disease an “Tropheryma whippeli”. Clin Microbiol Rev 14:561–583. doi: 10.1128/CMR.14.3.561-583.2001 PubMedCrossRefGoogle Scholar
  23. 23.
    Elkins C, Shuman TA, Pirolo JS (1999) Cardiac Whipple’s disease without digestive symptoms. Ann Thorac Surg 67:250–251. doi: 10.1016/S0003-4975(98)01204-1 PubMedCrossRefGoogle Scholar
  24. 24.
    Fenollar F, Puéchal X, Raoult R (2007) Whipple’s disease. N Engl J Med 356:55–56. doi: 10.1056/NEJMra062477 PubMedCrossRefGoogle Scholar
  25. 25.
    Topper R, Gartung C, Block F (2002) Neurologische komplikationen bei entzundlichen darmerkrankungen. Der Nervenarzt 73:489–500. doi: 10.1007/s00115-002-1335-y PubMedCrossRefGoogle Scholar
  26. 26.
    Matthews BR, Jones LK, Saad DA, Aksamit AJ, Josephs KA (2005) Cerebellar ataxia and central nervous system Whipple’s disease. Arch Neurol 62:618–620. doi: 10.1001/archneur.62.4.618 PubMedCrossRefGoogle Scholar
  27. 27.
    Fenollar F, Raoult D (2001) Whipple’s disease. Clin Diagn Lab Immunol 8:1–8. doi: 10.1128/CDLI.8.1.1-8.2001 PubMedCrossRefGoogle Scholar
  28. 28.
    Misbah SA, Mapstone NP (2000) Whipple’s disease revisited. J Clin Pathol 53:750–755. doi: 10.1136/jcp.53.10.750 PubMedCrossRefGoogle Scholar
  29. 29.
    Street S, Donoghue HD, Neild GH (1999) Tropheryma whipplei DNA in saliva of healthy people. Lancet 354:1178–1179. doi: 10.1016/S0140-6736(99)03065-2 PubMedCrossRefGoogle Scholar
  30. 30.
    Gerard A, Sarrot-Reynauld F, Liozon E et al (2002) Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine (Baltimore) 81:443–457. doi: 10.1097/00005792-200211000-00005 CrossRefGoogle Scholar
  31. 31.
    Di Stefano M, Jorizzo RA, Brusco G, Ceccheti L, Sciarra G, Loperfido S, Brandi G, Gasbarrini G, Corazza GR (1998) Bone mass and metabolism in Whipple’s disease: the role of hypogonadism. Scand J Gastroenterol 33:247–252. doi: 10.1080/00365529850172548 CrossRefGoogle Scholar
  32. 32.
    Keinath RD, Merell DE, Vlietstra R, Dobins WO (1985) III. Antibiotic treatment and relapse in Whipple’s disease: long-term follow-up of 88 patients. Gastroenterology 88:1967–1973Google Scholar
  33. 33.
    Knaapeen HK, Barrera P (2007) Treatment for Whipple’s disease. J Antimicrob Chemother 60:457–458. doi: 10.1093/jac/dkm259 CrossRefGoogle Scholar
  34. 34.
    Gallin JL, Farber JM, Holland SM, Nutman TB (1995) Interferon-gamma in the management of infectious diseases. Ann Intern Med 123:216–224PubMedGoogle Scholar
  35. 35.
    Schneider T, Stallmach A, von Herbay A, Marth T, Strober W, Zeitz M (1998) Treatment of refractory Whipple disease with interferon? Ann Intern Med 129:875–877PubMedGoogle Scholar
  36. 36.
    Ranjit N (2000) Ratnaike. Whipple’s disease. Postgrad Med J 76:760–766. doi: 10.1136/pmj.76.902.760 CrossRefGoogle Scholar
  37. 37.
    Marth T, Raoult D (2003) Whipple’s disease. Lancet 361:239–246. doi: 10.1016/S0140-6736(03)12274-X PubMedCrossRefGoogle Scholar
  38. 38.
    Misbah AS, Aslam A, Costello Ch (2004) Whipple’s disease. Lancet 363:654–656. doi: 10.1016/S0140-6736(04)15600-6 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Peter Jackuliak
    • 1
    Email author
  • Tomas Koller
    • 1
  • Lahim Baqi
    • 1
  • Lukas Plank
    • 2
  • Zora Lasabova
    • 3
  • Gabriel Minarik
    • 4
  • Juraj Payer
    • 1
  1. 1.5th Department of Internal Medicine, Faculty of MedicineComenius University, Faculty Hospital BratislavaBratislava 2Slovakia
  2. 2.Department of PathologyComenius UniversityMartinSlovakia
  3. 3.Department of Molecular BiologyComenius UniversityMartinSlovakia
  4. 4.Geneton Inc.BratislavaSlovakia

Personalised recommendations